$0.05 0.0 0.0%
Last Trade - 11/02/21
| Market Cap | ÂŁ289k |
| Enterprise Value | ÂŁ422k |
| Revenue | ÂŁn/a |
| Position in Universe | 6607th / 6647 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Bioscience Neutraceuticals, Inc., formerly JobLocationMap Inc., is a shell company. The Company is engaged in the development of visual job search service, which is focused on putting together job seekers and employers in JobLocationMap.com. Its Website intends to provide job seekers and employers with a platform to share their valid address and contact information to be shown as a pin on its provided map, manage their job description or their resume, and interact with a community of job searcher and employers from around the world. The Company is building an App for use with iPhone and Android. The App is focused on allowing users to search job listings to find a job location by map or use the App job search or browse jobs to find employment opportunities in an individual's area. The App seeks to connect people to job opportunities, Website global recruitment network, and to JobLocationMap platform.
| Last Annual | December 31st, 2019 |
| Last Interim | December 31st, 2019 |
| Incorporated | June 15, 2010 |
| Public Since | December 9, 2013 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Industrials |
| Industry | Professional & Commercial Services |
| Index | |
| Exchange | Pink Sheets on Nasdaq |
| Shares in Issue | 8,042,516 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 500 N Michigan Ave Ste 600, CHICAGO, 60611-3754, United States |
| Web | |
| Phone | +1 773 2368132 |
| Auditors | B F Borgers CPA PC |
As of 11/02/21, shares in Bioscience Neutraceuticals Inc are trading at $0.05, giving the company a market capitalisation of ÂŁ289k. This share price information is delayed by 15 minutes.
Shares in Bioscience Neutraceuticals Inc are currently trading at $0.05 and the price has moved by -97.49% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bioscience Neutraceuticals Inc price has moved by -98.03% over the past year.
There are no analysts currently covering Bioscience Neutraceuticals Inc.
Bioscience Neutraceuticals Inc is scheduled to issue upcoming financial results on the following dates:
Bioscience Neutraceuticals Inc does not currently pay a dividend.
Bioscience Neutraceuticals Inc does not currently pay a dividend.
Bioscience Neutraceuticals Inc does not currently pay a dividend.
To buy shares in Bioscience Neutraceuticals Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Bioscience Neutraceuticals Inc are currently trading at $0.05, giving the company a market capitalisation of ÂŁ289k.
Here are the trading details for Bioscience Neutraceuticals Inc:
Based on an overall assessment of its quality, value and momentum, Bioscience Neutraceuticals Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for Bioscience Neutraceuticals Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioscience Neutraceuticals Inc. Over the past six months, the relative strength of its shares against the market has been -79.65%. At the current price of $0.05, shares in Bioscience Neutraceuticals Inc are trading at -97.61% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Bioscience Neutraceuticals Inc.
Bioscience Neutraceuticals Inc's management team is headed by:
Here are the top five shareholders of Bioscience Neutraceuticals Inc based on the size of their shareholding:
